Cardiogen 20mg
Research-grade Cardiogen 20mg. 99% purity, third-party tested with published COA.
Ships from USA
1–3 day delivery
Free Shipping
On orders $150+
Peptide Handling & Storage Guide
Storage temperature, shelf life & reconstitution (PDF)
99%+ Purity
COA included
Same-Day Shipping
Orders before 2PM EST
Secure Checkout
SSL encrypted
Shipment Protection
Lost or damaged — reshipped free
Compound Information
- Type
- Synthetic tetrapeptide bioregulator
- Molecular Formula
- C18H31N7O9
- Molecular Weight
- 489.5 g/mol
- Purity
- 99%
- Sequence
- Ala-Glu-Asp-Arg (AEDR)
Reference chemistry (free base) from public chemical databases and peer-reviewed literature. For laboratory research identification only.
Research Use Only. This vial is bound for the lab bench — supplied for in-vitro scientific work exclusively, never for administration to any person or animal.
About Cardiogen
Cardiogen is a linear tetrapeptide of four L-amino acids, Ala-Glu-Asp-Arg (AEDR; ~C18H31N7O9, ~489.5 g/mol), one of the short "bioregulator" peptides characterized in the work of V. Kh. Khavinson and colleagues.
In a peer-reviewed study, the AEDR tetrapeptide was reported to increase expression of cytoskeletal proteins (actin, tubulin, vimentin) and nuclear-matrix proteins (lamins A and C) in cultured mouse embryonic fibroblasts. Published research on this peptide is preclinical and originates primarily from a single research group using in vitro systems; independent replication is limited. Note that "Cardiogen" is also an unrelated nuclear-cardiology product name (the Cardiogen-82 rubidium-82 generator) — a different product, not this peptide.
Frequently Asked Questions
What is Cardiogen?
Cardiogen is a trade name for a synthetic tetrapeptide, sequence Ala-Glu-Asp-Arg (AEDR), studied as a short peptide bioregulator in the Khavinson research framework. It is supplied for laboratory research use only.
What is Cardiogen peptide?
It is a four-amino-acid (tetrapeptide) research compound, Ala-Glu-Asp-Arg, examined in preclinical cell and tissue studies for effects on protein and gene expression. It is not a therapeutic product.
What is the sequence of Cardiogen?
The sequence is Ala-Glu-Asp-Arg (AEDR), a linear synthetic tetrapeptide of L-amino acids (~C18H31N7O9, ~489.5 g/mol).
What has Cardiogen been studied for in research?
In published preclinical work, the AEDR peptide was reported to increase expression of cytoskeletal proteins (actin, tubulin, vimentin) and nuclear-matrix proteins (lamins A and C) in cultured fibroblasts. These are laboratory findings in cell models and do not establish any effect in humans.
Is Cardiogen approved for human use?
No. Cardiogen (AEDR) is not approved by the FDA or any comparable authority and has no established human clinical use. Published data are preclinical only. It is intended solely for in vitro research.
Research & References
Independent databases and peer-reviewed literature for Cardiogen. Provided for research reference only.
External resources are independent and not affiliated with or endorsed by PHIOGEN. Listed for laboratory research reference only.
